Mayo Clinic Health System

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease2 trials

Phase

• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Janssen Research & Development, LLC1 trial
• Shanghai MicroPort Medical (Group) Co., Ltd.1 trial

Running trials

• Active, not recruiting

  Firehawk Rapamycin Target Eluting Coronary Stent North American Trial

  NCT04562532· Shanghai MicroPort Medical (Group) Co., Ltd.· Source

Closed trials

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source